Junshi Biosciences Announces Approval for Marketing of VV116 in China
Junshi Biosciences Announces Approval for Marketing of VV116 in China - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Page 6 - Junshi Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Junshi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Junshi Bioscience Today - Breaking & Trending Today
Junshi Biosciences Announces Toripalimab as Perioperative
SHANGHAI, China, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading...
Source: globenewswire.com
Junshi Biosciences Announces Acceptance of NDA for VV116 in
SHANGHAI, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading...
Source: globenewswire.com
Junshi Biosciences Announces Toripalimab as Perioperative Treatment for Operable NSCLC Patients Met Primary Endpoint in Phase 3 Clinical Study
SHANGHAI, China, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated
Source: finanznachrichten.de
Outlook on the Nasopharyngeal Cancer Global Market to 2028 - Featuring Biocon, Bristol-Myers Squibb, Cyclacel Pharmaceuticals and Eli Lilly and Co Among Others
/PRNewswire/ -- The "Global Nasopharyngeal Cancer Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The...
Source: prnewswire.com